Reducing neonatal mortality and expenditure in the era of health care crisis: Is it possible

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue SUPPL. 5, 2012, Pages 1-3

  Mussap, Michele ^a   Fanos, Vassilios ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ASPHYXIA; BACTERIUM IDENTIFICATION; BODY FLUID; CAUSE OF DEATH; CHILDHOOD MORTALITY; CLINICAL DECISION MAKING; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; CULTURE MEDIUM; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; EDITORIAL; FETUS DISEASE; HEALTH CARE ACCESS; HEALTH CARE CONCEPTS; HEALTH CARE COST; HEALTH CARE CRISIS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL INFECTION; INBORN ERROR OF METABOLISM; INCOME; INFANTILE DIARRHEA; LABORATORY DIAGNOSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DIAGNOSIS; MOLECULAR MECHANICS; NEONATOLOGY; NEWBORN CARE; NEWBORN DEATH; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN PERIOD; NEWBORN SCREENING; NEWBORN TETANUS; OUTCOME ASSESSMENT; PATIENT CARE; PNEUMONIA; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SURVIVAL RATE; TANDEM MASS SPECTROMETRY; TRANSLATIONAL RESEARCH;

DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INCOME; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; NEONATOLOGY;

EID: 84867033185     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.715434     Document Type: Editorial

References (14)

1. You D, Jones G, Wardlaw T, on behalf of the United Nations Interagency Group for Child Mortality Estimation. Levels and trends in child mortality: report 2011. Geneva, Swtizerland: UNICEF; 2011.
2. World Health Organization. The global burden of disease: 2004 update. Geneva, Swtizerland: World Health Organization; 2008 (ISBN 978 92 4 156371 0).
3. Porter ME. What is value in health care? N Engl J Med 2010;363: 2477-2481.
4. Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med 2009;361:109-112.
5. Atzori L, Antonucci R, Barberini L, Grifn JL, Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med 2009;22 Suppl 3:50-53.
6. Fanos V, Barberini L, Antonucci R, Atzori L. Metabolomics in neonatology and pediatrics. Clin Biochem 2011;44:452-454.
7. Fanos V, Barberini L, Antonucci R, Atzori L. Pharma-metabolomics in neonatology: is it a dream or a fact? Curr Pharm Des 2012;18: 2996-3006.
8. Fanos V, Antonucci R, Barberini L, Noto A, Atzori L. Clinical application of metabolomics in neonatology. J Matern Fetal Neonatal Med 2012;25 Suppl 1:104-109.
9. Fanos V, Antonucci R, Barberini L, Atzori L. Urinary metabolomics in newborns and infants. Adv Clin Chem 2012;58:194-218.
10. Fanos V, Antonucci R, Zafanello M, Mussap M. Old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on uNGAL and on metabolomics. Curr Med Chem 2012, August 9 (Epub ahead of print).
11. Syggelou A, Iacovidou N, Atzori L, Xanthos T, Fanos V. Metabolomics in the developing human being. Ped Clin North Am 2012, in press.
12. Fanos V, Mussap M, Noto A, Atzori L: Metabolomics in perinatology: where are we now? Acta Medica Portuguesa 2012 (in press).
13. Fanos V, van den Anker J, Noto A, Mussap M. Metabolomics in neonatology: fact or fction? Sem Fetal Neonat Med (submitted).
14. Mussap M, Noto A, Cibecchini F, Fanos V. Emerging biomarkers in neonatal sepsis. Drugs of the Future 2012;37(5):353-359.